Soon people will be able to subdue a severe allergic reaction with a nasal spray instead of an injection.
On August 9, the U.S. Food and Drug Administration approved the first epinephrine nasal spray for the treatment of severe allergic reactions, including anaphylaxis, in adults and kids who weigh 30 kilograms or more.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.